Carfilzomib, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple Myeloma: Final Results from the NCI Phase 2 Pilot Study
Year: 2014
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Ola Landgren, Mark Roschewski, Sham Mailankody, Mary Kwok, Elisabet E. Manasanch, Manisha Bhutani, Nishant Tageja, Dickran Kazandjian, Adriana Zingone, Rene Costello, Debra Burton, Yong Zhang, Peter Wu, George Carter, Marcia Mulquin, Diamond Zuchlinski, Ashley Carpenter, Verena Gounden, Candice Morrison, Irina Maric, Katherine R. Calvo, Raul C. Braylan, Constance Yuan, Maryalice Stetler-Stevenson, Diane C Arthur, Liza Lindenberg, Kurdziel Karen, Peter Choyke, Seth M. Steinberg, William D Figg, Neha Korde
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2302746114